IBB
IBB
iShares Biotechnology ETF • IShares
$167.50 ▲ 1.97% (+3.23)
Managing Company IShares
Asset Under Management $7.53B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $123.61
Volume 1,012,187
Avg Volume 1,524,465
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Managing Company IShares
Asset Under Management $7.53B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $123.61
Volume 1,012,187
Avg Volume 1,524,465
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 7.42% | 4.47M | $600.84M |
 VRTX | Vertex Pharmaceuticals Incorporated | 7.40% | 1.34M | $599.69M |
 AMGN | Amgen Inc. | 7.13% | 1.72M | $577.63M |
 REGN | Regeneron Pharmaceuticals, Inc. | 5.69% | 750.12K | $461.16M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.61% | 969.09K | $292.65M |
 ARGX | argenx SE | 3.49% | 337.91K | $282.49M |
 NTRA | Natera, Inc. | 2.68% | 970.14K | $216.70M |
 BIIB | Biogen Inc. | 2.61% | 1.08M | $211.57M |
 RVMD | Revolution Medicines, Inc. | 2.47% | 1.27M | $199.97M |
 ILMN | Illumina, Inc. | 2.20% | 1.10M | $178.52M |
 UTHR | United Therapeutics Corporation | 2.15% | 312.10K | $173.78M |
 INSM | Insmed Incorporated | 2.07% | 1.57M | $167.93M |
 ONC | BeOne Medicines Ltd. | 1.86% | 523.58K | $150.75M |
 INCY | Incyte Corporation | 1.73% | 1.45M | $140.48M |
 MRNA | Moderna, Inc. | 1.55% | 2.66M | $125.66M |
 NBIX | Neurocrine Biosciences, Inc. | 1.41% | 719.71K | $113.93M |
 ROIV | Roivant Sciences Ltd. | 1.33% | 3.60M | $107.98M |
 EXEL | Exelixis, Inc. | 1.15% | 1.85M | $93.48M |
 GMAB | Genmab A/S | 1.14% | 3.52M | $92.64M |
 IONS | Ionis Pharmaceuticals, Inc. | 1.13% | 1.19M | $91.23M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Denmark
United Kingdom
Canada
Ireland
Germany
France
Switzerland Other
0.17%
Jersey
China
Spain
Australia
Singapore
Italy
Cayman Islands
Iceland.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Denmark United Kingdom Canada Ireland Germany France Switzerland Other
0.17% Jersey China Spain Australia Singapore Italy Cayman Islands Iceland Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
Weight: 7.42% Shares: 4.47M Value: $600.84M
VRTX
Vertex Pharmaceuticals Incorporated
Weight: 7.40% Shares: 1.34M Value: $599.69M
AMGN
Amgen Inc.
Weight: 7.13% Shares: 1.72M Value: $577.63M
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 5.69% Shares: 750.12K Value: $461.16M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 3.61% Shares: 969.09K Value: $292.65M
ARGX
argenx SE
Weight: 3.49% Shares: 337.91K Value: $282.49M
NTRA
Natera, Inc.
Weight: 2.68% Shares: 970.14K Value: $216.70M
BIIB
Biogen Inc.
Weight: 2.61% Shares: 1.08M Value: $211.57M
RVMD
Revolution Medicines, Inc.
Weight: 2.47% Shares: 1.27M Value: $199.97M
ILMN
Illumina, Inc.
Weight: 2.20% Shares: 1.10M Value: $178.52M
UTHR
United Therapeutics Corporation
Weight: 2.15% Shares: 312.10K Value: $173.78M
INSM
Insmed Incorporated
Weight: 2.07% Shares: 1.57M Value: $167.93M
ONC
BeOne Medicines Ltd.
Weight: 1.86% Shares: 523.58K Value: $150.75M
INCY
Incyte Corporation
Weight: 1.73% Shares: 1.45M Value: $140.48M
MRNA
Moderna, Inc.
Weight: 1.55% Shares: 2.66M Value: $125.66M
NBIX
Neurocrine Biosciences, Inc.
Weight: 1.41% Shares: 719.71K Value: $113.93M
ROIV
Roivant Sciences Ltd.
Weight: 1.33% Shares: 3.60M Value: $107.98M
EXEL
Exelixis, Inc.
Weight: 1.15% Shares: 1.85M Value: $93.48M
GMAB
Genmab A/S
Weight: 1.14% Shares: 3.52M Value: $92.64M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 1.13% Shares: 1.19M Value: $91.23M